Array BioPharma To Present At The Bank of America Merrill Lynch Healthcare Conference and the UBS Global Healthcare Conference

May 12, 2014, 12:00 ET from Array BioPharma Inc.

BOULDER, Colo., May 12, 2014 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Bank of America Merrill Lynch Healthcare Conference in Las Vegas and the UBS Global Healthcare Conference in New York City.  The public is welcome to participate in the conferences through webcasts on the Array BioPharma website:  www.arraybiopharma.com.   

Event:

Bank of America Merrill Lynch Healthcare Conference

Date:

Tuesday, May 13, 2014

Time:

12:00 p.m. PDT

Location:

Encore at the Wynn, Las Vegas, NV

Event:

UBS Global Healthcare Conference

Date:

Tuesday, May 20, 2014

Time:

8:00 a.m. EDT

Location:

Sheraton New York Hotel, NYC, NY

About Array BioPharma Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.  Seven Phase 3 or pivotal studies are already in progress, or are planned to begin this year. These programs include the wholly-owned hematology drug, filanesib (ARRY-520) for multiple myeloma and two partnered cancer drugs, selumetinib (AstraZeneca) and binimetinib (MEK162 / Novartis).  For more information on Array, please go to www.arraybiopharma.com.

CONTACT:

Tricia Haugeto

Array BioPharma Inc.

303-386-1193

thaugeto@arraybiopharma.com

Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO

SOURCE Array BioPharma Inc.



RELATED LINKS

http://www.arraybiopharma.com